Shi‐Xun Ma
Papers
6
Total Citations
121
H-Index
5
About
Shi‐Xun Ma is a leading surgical researcher whose work centers on advancing minimally invasive and robotic-assisted procedures for gastrointestinal and pancreatic cancers. His major contributions lie in rigorously evaluating the safety, efficacy, and outcomes of robotic surgery compared to traditional laparoscopic and open approaches. Through systematic reviews and meta-analyses, Ma has provided critical evidence that robotic-assisted distal pancreatectomy and right colectomy can offer comparable or improved short-term outcomes, with his landmark 2018 studies each garnering 48 citations. He has also pioneered novel techniques, such as the da Vinci “3+2” mode for radical gastrectomy, and explored the frontier of telerobotic surgery, demonstrating the feasibility of cholecystectomy over a 5G network in a 2025 clinical trial. Beyond surgical technique, Ma’s research extends to prognostic biomarkers, where his work on the systemic inflammatory response index (SIRI) in gastric cancer patients has opened new avenues for personalized risk assessment. With a cumulative impact spanning over 120 citations, Ma’s investigations are shaping the future of oncologic surgery, making him a key figure in the integration of robotics and digital health into clinical practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6